Clinicopathologic and genetic features of the starry-sky pattern in double-expressor diffuse large B-cell lymphoma

Hum Pathol. 2023 Sep:139:106-116. doi: 10.1016/j.humpath.2023.07.008. Epub 2023 Jul 29.

Abstract

Double expressor lymphoma (DEL) is a subset of diffuse large B-cell lymphoma (DLBCL) characterized by the co-expression of MYC and BCL2 proteins with a poor prognosis. However, there are no standard criteria for evaluating the morphologic features of DEL. We aimed to analyze the prognostic value of the starry-sky pattern (SSP) and its correlation with clinicopathologic and genetic features in 153 DEL cases. The SSP was significantly associated with aggressive parameters, including c-MYC overexpression, CD5 expression, higher IPI, and age-adjusted IPI. In the univariate survival analyses, the presence of SSP was associated with unfavorable progression-free survival (PFS) (p = 0.040), and tended towards an adverse overall survival (OS) (p = 0.061). However, when c-MYC was overexpressed, SSP was significantly correlated with inferior OS (p = 0.019). In the multivariate survival analysis, SSP was also associated with poor PFS (p = 0.048). Additionally, next-generation sequencing data revealed SSP was significantly associated with the KMT2D mutation and had different genetic mutation profiles from non-SSP. In conclusion, SSP may represent morphologic characteristics of aggressiveness in DEL.

Keywords: Diffuse large B-cell lymphoma; Double expressor lymphoma; KMT2D; Prognosis; Starry-sky pattern; c-MYC.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / pathology
  • Prognosis
  • Progression-Free Survival
  • Proto-Oncogene Proteins c-bcl-2 / genetics
  • Proto-Oncogene Proteins c-myc* / genetics
  • Proto-Oncogene Proteins c-myc* / metabolism

Substances

  • Proto-Oncogene Proteins c-myc
  • Proto-Oncogene Proteins c-bcl-2